These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 35507499)

  • 1. First-Line Catheter Ablation of Monomorphic Ventricular Tachycardia in Cardiomyopathy Concurrent With Defibrillator Implantation: The PAUSE-SCD Randomized Trial.
    Tung R; Xue Y; Chen M; Jiang C; Shatz DY; Besser SA; Hu H; Chung FP; Nakahara S; Kim YH; Satomi K; Shen L; Liang E; Liao H; Gu K; Jiang R; Jiang J; Hori Y; Choi JI; Ueda A; Komatsu Y; Kazawa S; Soejima K; Chen SA; Nogami A; Yao Y;
    Circulation; 2022 Jun; 145(25):1839-1849. PubMed ID: 35507499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventive or Deferred Ablation of Ventricular Tachycardia in Patients With Ischemic Cardiomyopathy and Implantable Defibrillator (BERLIN VT): A Multicenter Randomized Trial.
    Willems S; Tilz RR; Steven D; Kääb S; Wegscheider K; Gellér L; Meyer C; Heeger CH; Metzner A; Sinner MF; Schlüter M; Nordbeck P; Eckardt L; Bogossian H; Sultan A; Wenzel B; Kuck KH;
    Circulation; 2020 Mar; 141(13):1057-1067. PubMed ID: 32000514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does Timing of Ventricular Tachycardia Ablation Affect Prognosis in Patients With an Implantable Cardioverter Defibrillator? Results From the Multicenter Randomized PARTITA Trial.
    Della Bella P; Baratto F; Vergara P; Bertocchi P; Santamaria M; Notarstefano P; Calò L; Orsida D; Tomasi L; Piacenti M; Sangiorgio S; Pentimalli F; Pruvot E; De Sousa J; Sacher F; Tritto M; Rebellato L; Deneke T; Romano SA; Nesti M; Gargaro A; Giacopelli D; Peretto G; Radinovic A
    Circulation; 2022 Jun; 145(25):1829-1838. PubMed ID: 35369700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial.
    Kuck KH; Schaumann A; Eckardt L; Willems S; Ventura R; Delacrétaz E; Pitschner HF; Kautzner J; Schumacher B; Hansen PS;
    Lancet; 2010 Jan; 375(9708):31-40. PubMed ID: 20109864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substrate Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia.
    Arenal Á; Ávila P; Jiménez-Candil J; Tercedor L; Calvo D; Arribas F; Fernández-Portales J; Merino JL; Hernández-Madrid A; Fernández-Avilés FJ; Berruezo A
    J Am Coll Cardiol; 2022 Apr; 79(15):1441-1453. PubMed ID: 35422240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate.
    AbdelWahab A; Sapp J
    Curr Cardiol Rep; 2017 Sep; 19(11):105. PubMed ID: 28900864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pan-Asia United States PrEvention of Sudden Cardiac Death Catheter Ablation Trial (PAUSE-SCD): rationale and study design.
    Chen M; Wu S; Yao Y; Jiang J; Jiang C; Xue Y; Zhan X; Hu H; Fu G; Gu K; Liu H; Ding L; Jiang R; Chung FP; Lin YJ; Hori Y; Komatsu Y; Ueda A; Soejima K; Kim YH; Nogami A; Nakahara S; Chen SA; Tung R;
    J Interv Card Electrophysiol; 2020 Mar; 57(2):271-278. PubMed ID: 30891654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implantable cardioverter defibrillators. Prophylactic use: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(14):1-74. PubMed ID: 23074465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term benefit of first-line peri-implantable cardioverter-defibrillator implant ventricular tachycardia-substrate ablation in secondary prevention patients.
    Acosta J; Cabanelas N; Penela D; Fernández-Armenta J; Andreu D; Borràs R; Korshunov V; Cabrera M; Vasanelli F; Arbelo E; Guasch E; Martínez M; Tolosana JM; Mont L; Berruezo A
    Europace; 2017 Jun; 19(6):976-982. PubMed ID: 27353322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radio-frequency ablation as primary management of well-tolerated sustained monomorphic ventricular tachycardia in patients with structural heart disease and left ventricular ejection fraction over 30%.
    Maury P; Baratto F; Zeppenfeld K; Klein G; Delacretaz E; Sacher F; Pruvot E; Brigadeau F; Rollin A; Andronache M; Maccabelli G; Gawrysiak M; Brenner R; Forclaz A; Schlaepfer J; Lacroix D; Duparc A; Mondoly P; Bouisset F; Delay M; Hocini M; Derval N; Sadoul N; Magnin-Poull I; Klug D; Haïssaguerre M; Jaïs P; Della Bella P; De Chillou C
    Eur Heart J; 2014 Jun; 35(22):1479-85. PubMed ID: 24536081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Substrate Modification by Catheter Ablation on Implantable Cardioverter-Defibrillator Interventions in Patients With Unstable Ventricular Arrhythmias and Coronary Artery Disease: Results From the Multicenter Randomized Controlled SMS (Substrate Modification Study).
    Kuck KH; Tilz RR; Deneke T; Hoffmann BA; Ventura R; Hansen PS; Zarse M; Hohnloser SH; Kautzner J; Willems S;
    Circ Arrhythm Electrophysiol; 2017 Mar; 10(3):. PubMed ID: 28292751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic catheter ablation for induced monomorphic ventricular tachycardia in patients with implantable cardioverter defibrillators as primary prevention.
    Hayashi T; Fukamizu S; Hojo R; Komiyama K; Tanabe Y; Tejima T; Soejima K; Nishizaki M; Hiraoka M; Ako J; Momomura S; Sakurada H
    Europace; 2013 Oct; 15(10):1507-15. PubMed ID: 23603305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First-line ablation of ventricular tachycardia in ischemic cardiomyopathy: stratification of outcomes by left ventricular function.
    Briceño DF; Romero J; Patel K; Liaqat W; Zhang XD; Alviz I; Yang R; Rodriguez D; Lakkireddy D; Rocca DD; Tarantino N; Gopinathannair R; Natale A; Di Biase L
    J Interv Card Electrophysiol; 2021 Nov; 62(2):391-400. PubMed ID: 33179155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic catheter ablation of ventricular tachycardia in ischemic cardiomyopathy: a systematic review and meta-analysis of randomized controlled trials.
    Atti V; Vuddanda V; Turagam MK; Vemula P; Shah Z; Nagam H; Yandrapalli S; Jazayeri MA; Koerber S; Gonzalez JV; Natale A; Di Biase L; Lakkireddy DR
    J Interv Card Electrophysiol; 2018 Nov; 53(2):207-215. PubMed ID: 29680972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of Catheter Ablation in Arrhythmogenic Right Ventricular Cardiomyopathy Without Background Implantable Cardioverter Defibrillator Therapy: A Multicenter International Ventricular Tachycardia Registry.
    Santangeli P; Tung R; Xue Y; Chung FP; Lin YJ; Di Biase L; Zhan X; Lin CY; Wei W; Mohanty S; Burkhardt DJ; Zado ES; Callans DJ; Marchlinski FE; Wu S; Chen SA; Natale A
    JACC Clin Electrophysiol; 2019 Jan; 5(1):55-65. PubMed ID: 30678787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes after catheter ablation of ventricular tachycardia without implantable cardioverter-defibrillator in selected patients with arrhythmogenic right ventricular cardiomyopathy.
    Gandjbakhch E; Laredo M; Berruezo A; Gourraud JB; Sellal JM; Martins R; Sacher F; Pison L; Pruvot E; Jáuregui B; Frontera A; Kumar S; Wong T; DellaBella P; Maury P
    Europace; 2021 Sep; 23(9):1428-1436. PubMed ID: 34427302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and relevance of nonreentrant monomorphic ventricular tachycardia in patients with frequent implantable cardioverter defibrillator interventions.
    Fiek M; Remp T; Fleckenstein M; Pohl T; Deiss M; Reithmann C
    J Interv Card Electrophysiol; 2015 Mar; 42(2):151-60. PubMed ID: 25620151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catheter ablation for ventricular tachycardia in patients with an implantable cardioverter defibrillator (CALYPSO) pilot trial.
    Al-Khatib SM; Daubert JP; Anstrom KJ; Daoud EG; Gonzalez M; Saba S; Jackson KP; Reece T; Gu J; Pokorney SD; Granger CB; Hess PL; Mark DB; Stevenson WG
    J Cardiovasc Electrophysiol; 2015 Feb; 26(2):151-7. PubMed ID: 25332150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of early ventricular tachycardia ablation in patients with an implantable cardioverter-defibrillator: An updated systematic review and meta-analysis of randomized controlled trials.
    Prasitlumkum N; Navaravong L; Desai A; Desai D; Cheungpasitporn W; Rattanawong P; Bunch TJ; Jongnarangsin K; Chokesuwattanaskul R
    Heart Rhythm; 2022 Dec; 19(12):2054-2061. PubMed ID: 35820619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MAGNETIC VT study: a prospective, multicenter, post-market randomized controlled trial comparing VT ablation outcomes using remote magnetic navigation-guided substrate mapping and ablation versus manual approach in a low LVEF population.
    Di Biase L; Tung R; Szili-Torok T; Burkhardt JD; Weiss P; Tavernier R; Berman AE; Wissner E; Spear W; Chen X; Neužil P; Skoda J; Lakkireddy D; Schwagten B; Lock K; Natale A;
    J Interv Card Electrophysiol; 2017 Apr; 48(3):237-245. PubMed ID: 28064433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.